Objective(s): Biocompatibility, non-toxicity, minimal allergenicity, and biodegradability are all characteristics of chitosan. Other biological properties of chitosan have been reported, including antitumor, antimicrobial and antioxidant activities. This research aim is the synthesis of drug compounds by preparation and characterization of polymer chitosan Schiff base and chitosan Schiff base / Poly vinyl alcohol / poly vinyl pyrrolidone Nanocomposite and study applications (anticancer cell line, antimicrobial agents). Methods: Chitosan Schiff base was prepared from the reaction of chitosan with carbonyl group of 4-nitro benzaldehyde. Polymer blend have been prepared by solution casting method. Chitosan Schiff base mixing with PVA and PVP. Green synthesis of AuNPs and AgNPs by onion peals extract as reducing agent. Nanocomposites were prepared by mixing 10 mL of chitosan Schiff base, 5 mL PVA and 5 mL of PVP with 25 mL of two different concentrations (100, 200 ppm) of AuNPs and AgNPs. In vitro bacterial activities polymer blends and Au, Ag nano composites were performed against pathogenic bacteria such as the Acinetobacter baumannii, Staphylococcus aureus, Pseudomonas aeruginosa and Esherichia coli. Cancer cell line (AMJ-13) cell line. Results: The prepared AgNPs and AuNPs were characterized by UV-visible spectroscopy, SEM microscopy and XRD analysis. UV-vis spectrum of AuNPs at 543 nm and AgNPs at 425 nm, particles size of AuNPs 24.74 nm and AgNPs 18.77 nm. The polymer blends and nano composites were characterized by FT-IR, SEM, DSC and TGA. DSC analysis investigated the polymer blend and nano composites shows a good thermal stability for all prepared compounds. The inhibition zone of blend and nanocomposites The Inhibition zone of blend and Nano composites ranging between (8-15) millimetre with concentration of 20 mg. The inhibition rate of blend and Nanocomposites ranging between (1.33 – 77.33) for all compounds. IC 50 of blend and Nanocomposites ranging between (26.04 - 183.56) µg for all compounds. Conclusions: The prepared AgNPs and AuNPs were characterized by UV-visible spectroscopy, SEM microscopy and XRD analysis. UV-vis spectrum of AuNPs at 543 nm and AgNPs at 425 nm, particles size of AuNPs 24.74 nm and AgNPs 18.77 nm. The polymer blends and nano composites were characterized by FT-IR, SEM, DSC and TGA. DSC analysis investigated the polymer blend and nano composites shows a good thermal stability for all prepared compounds. The inhibition zone of blend and nanocomposites The Inhibition zone of blend and Nano composites ranging between (8-15) millimetre with concentration of 20 mg. The inhibition rate of blend and Nanocomposites ranging between (1.33 – 77.33) for all compounds. IC 50 of blend and Nanocomposites ranging between (26.04 - 183.56) µg for all compounds.
Tetradentate complexes type [M (HL) 2] were prepared from the reaction of 2-hydroxy -1, 2-diphynel-ethanone oxime [H2L] and KOH with ( Mn II, Fe II, Co II, Ni II , Cu II and Hg II ), in methanol with (2:1) metal: ligand ratio. The general formula for Cu II and Mn II complexes are [M (HL) 2 Cl.H2O] K, for Co II [Co (HL) 2. H2O] and [M (HL) 2] for the rest of complexes. All compounds were characterised by spectroscopic methods, I.R, U.V-Vis, H.P.L.C, atomic absorption and conductivity measurements chloride content. From the data of these measurements, the proposed molecular structures for Fe II and Hg II complexes are tetrahedrals, while Mn II and Cu II complexes are octahedrals, Ni II complex adopting square planar structure and the complex
... Show MoreA sensitivity-turbidimetric method at (0-180o) was used for detn. of mebeverine in drugs by two solar cell and six source with C.F.I.A.. The method was based on the formation of ion pair for the pinkish banana color precipitate by the reaction of Mebeverine hydrochloride with Phosphotungstic acid. Turbidity was measured via the reflection of incident light that collides on the surface particles of precipitated at 0-180o. All variables were optimized. The linearity ranged of Mebeverine hydrochloride was 0.05-12.5mmol.L-1, the L.D. (S/N= 3)(3SB) was 521.92 ng/sample depending on dilution for the minimum concentration , with correlation coefficient r = 0.9966while was R.S.D%
... Show MoreBackground This study aimed to evaluate the efficacy of once-daily liraglutide as an add-on to oral antidiabetics (OADs) on glycemic control and body weight in obese patients with inadequately controlled type 2 diabetes (T2D). Methods A total of 27 obese T2D patients who received 7 months (0.6 mg/day for the first month, 1.2 mg/day for 3 months, and 1.8 mg/day for 3 months) of liraglutide treatment as an add-on to OADs were included. Data on body weight (kg), fasting plasma glucose (FPG, mg/dL), postprandial glucose (PPG, mg/dL), and HbA1c (%), were recorded. Results Liraglutide doses of 1.2 mg/day and 1.8 mg/day were associated with significant decreases in body weight (by 8.0% and 11.9%, respectively, p < 0.01 for each) and HbA1c (by 20.0
... Show MoreNew metal ion complexes were synthesized with the general formula; K[PtLCl4], [ReLCl4] and K[ML(Cl)2] where M = Pd(II), Cd(II), Zn(II) and Hg(II), from the Azo ligand (HL) [2-Hydroxy-3-((5-mercapto-1,3,4-thiadiazol-2-yl)diazenyl)-1-naphth aldehyde] (HL) the ligand was synthesized from (2-hydroxy-1-naphthaldehyde) and (5-amino-1,3,4-thiadiazole-2-thiol). The ligand and its metal complexes are characterized by phisco- chemical spectroscopic techniques (FT.IR, UV-Vis and Mass spectra, elemental analysis, molar conductivity, Atomic Absorption, Chloride contain and magnetic susceptibility). The spectral data suggest that the (HL) behaves as a bidentate ligand in all complexes. These studies revealed tetrahedral geometries for all metal complexes
... Show More